Registrations Open for 2022 AACC Annual Scientific Meeting & Clinical Lab Expo
By LabMedica International staff writers Posted on 02 Mar 2022 |
The American Association for Clinical Chemistry (AACC Washington, D.C., USA) has announced that Expo only registration is now open for the Annual Scientific Meeting & Clinical Lab Expo for those who wish to be in-the-know as exhibitors roll out the latest technologies and services.
The 2022 AACC Annual Scientific Meeting & Clinical Lab Expo will be held at the McCormick Place Convention Center in Chicago, USA on July 24-28, 2022. The event will bring together the global laboratory medicine community for AACC's world-renowned exposition of clinical laboratory products and services. At the event, attendees will have the opportunity to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
As the place to learn about breakthrough innovations from industry leaders, AACC’s Clinical Lab Expo gives attendees the opportunity to explore new advances that ignite the collective passion for discovery and practical solutions that fit the lab’s needs. The AACC Clinical Lab Expo has more than 200 new product introductions each year, allowing attendees to learn about cutting edge technology. In addition, attendees can hear vital research and learn about important changes in the field. With more than 250 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions, they can design an educational experience that meets their need to stay ahead of changes in the field. Those interested can join the global laboratory medicine community for AACC's world-renowned exposition of clinical laboratory products and services for a registration fee of just USD 10.
Related Links:
AACC
Latest Industry News
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus